6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Hypercalcemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L | 1 |
| Coleman, RE; Kanis, JA; McCloskey, EV; O'Rourke, NP; Rosini, S | 1 |
2 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Hypercalcemia
| Article | Year |
|---|---|
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid | 2002 |
Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).
Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Pilot Projects | 1994 |